100 Chapter 5 21. Kempton MJ, Underwood TSA, Brunton S, et al. Acomprehensive testing protocol for MRI neuroanatomical segmentation techniques: evaluation of a novel lateral ventricle segmentation method. Neuroimage. 2011;58:1051-1059. 22. De Bresser J, Kuijf HJ, Zaanen K, et al. White matter hyperintensity shape and location feature analysis on brain MRI; proof of principle study in patients with diabetes. Sci Rep. 2018;8:1-10. 23. Sigurdsson S, Aspelund T, Forsberg L, et al. Brain tissue volumes in the general population of the elderly The AGES-Reykjavik Study. Neuroimage. 2012;59:3862-3870. 24. Zijdenbos AP, Forghani R, Evans AC. Automatic “pipeline” analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans Med Imaging. 2002;21:1280-1291. 25. Kant IMJ, Mutsaerts HJMM, van Montfort SJT, et al. The association between frailty and MRI features of cerebral small vessel disease. Sci Rep. 2019;9:1-9. 26. Kant IMJ, de Bresser J, van Montfort SJT, et al. Preoperative brain MRI features and occurrence of postoperative delirium. J Psychosom Res. 2021;140:110301. 27. Love S, Miners JS. White matter hypoperfusion and damage in dementia: post-mortem assessment. Brain Pathol. 2015;25:99-107. 28. Godin O, Tzourio C, Rouaud O, et al. Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI Study. J Alzheimer’s Dis. 2010;20:453- 463. 29. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk white matter hyperintensity progression matters. Neurology. 2009;73:120-125. 30. Prins ND, Van Dijk EJ, Den Heijer T, et al. Cerebral small-vessel dis- ease and decline in information processing speed, executive function and memory. Brain. 2005;128:2034-2041.
RkJQdWJsaXNoZXIy MTk4NDMw